检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

ASXL1 Mutations Predict Inferior Molecular Response to Nilotinib Treatment in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

Thomas Ernst, Lioba Schönfeld,Jenny Rinke,Anna Hinze,Saskia N. Nagel,Vivien Schäfer,Thomas Schenk,Christian Fabisch,Tim H. Brümmendorf,Andreas Burchert,Philipp le Coutre,Stefan W. Krause,Susanne Saussele,Fatemeh Safizadeh,Markus Pfirrmann,Andreas Hochhaus

Blood（2022）

引用 6|浏览9
暂无评分
关键词
chronic myeloid leukemia,nilotinib treatment,mutations
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要